DE19648545B4
(en)
†
|
1996-11-25 |
2009-05-07 |
Ceramtec Ag |
Monolithic multilayer actuator with external electrodes
|
CA2294345C
(en)
*
|
1997-06-20 |
2006-11-21 |
Sabine Eggers |
A skin-protective composition
|
US6096332A
(en)
*
|
1998-06-30 |
2000-08-01 |
Mcneil-Ppc, Inc. |
Adding pharmaceutically active compounds to substrates
|
IL137559A
(en)
*
|
2000-07-27 |
2006-12-31 |
Amnon Sintov |
Transdermal drug delivery system
|
CA2431205C
(en)
*
|
2000-12-05 |
2005-08-23 |
Alexander Macgregor |
Hydrostatic delivery system for controlled delivery of agent
|
BRPI0214256B8
(en)
*
|
2001-11-19 |
2021-05-25 |
Medigene Ag |
medicine
|
DE10156794B4
(en)
*
|
2001-11-19 |
2006-05-18 |
Medigene Ag |
Medicines for the treatment of warts
|
US20050032896A1
(en)
*
|
2002-06-21 |
2005-02-10 |
Liisa Neumann |
Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism
|
US20050095281A1
(en)
*
|
2003-03-14 |
2005-05-05 |
Optime Therapeutics, Inc. |
Liposomal formulations and methods of use
|
ES2237298B1
(en)
|
2003-07-16 |
2006-11-01 |
Italfarmaco, S.A. |
SEMISOLID MUCOADHESIVE FORMULATIONS.
|
GB0317999D0
(en)
*
|
2003-07-31 |
2003-09-03 |
Univ Liege |
Improvements in or relating to drug delivery systems
|
AU2004270266B2
(en)
*
|
2003-09-09 |
2011-02-10 |
3M Innovative Properties Company |
Concentrated antimicrobial compositions and methods
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
BRPI0415215B8
(en)
|
2003-10-09 |
2021-05-25 |
Medigene Ag |
use of polyphenol in drug preparation
|
US20050079235A1
(en)
*
|
2003-10-09 |
2005-04-14 |
Eggert Stockfleth |
Use of a polyphenol for the treatment of actinic keratosis
|
EP1691743A4
(en)
*
|
2003-11-11 |
2010-08-25 |
Univ Minnesota |
Regulation of cell membrane-mediated effects
|
US8796332B2
(en)
|
2004-08-03 |
2014-08-05 |
Regents Of The University Of Minnesota |
Compositions and methods for controlling infections
|
CA2578404A1
(en)
*
|
2004-08-23 |
2006-03-02 |
Auckland Uniservices Limited |
Gastric therapies and compositions therefor
|
US8535709B2
(en)
*
|
2004-12-13 |
2013-09-17 |
Southeastern Medical Technologies, Llc |
Agents for controlling biological fluids and methods of use thereof
|
EP1833298B1
(en)
*
|
2004-12-17 |
2013-05-08 |
Halldor Thormar |
Stable concentrated anti-bacterial emulsions of monocaprin in water
|
CA2599653A1
(en)
|
2005-03-10 |
2006-09-21 |
3M Innovative Properties Company |
Methods of reducing microbial contamination
|
US8476319B2
(en)
|
2005-03-10 |
2013-07-02 |
3M Innovative Properties Company |
Methods of treating ear infections
|
CA2598985A1
(en)
*
|
2005-03-10 |
2006-09-21 |
3M Innovative Properties Company |
Antimicrobial pet wipes and methods
|
US20060229364A1
(en)
*
|
2005-03-10 |
2006-10-12 |
3M Innovative Properties Company |
Antiviral compositions and methods of use
|
MX2007010908A
(en)
|
2005-03-10 |
2007-12-05 |
3M Innovative Properties Co |
Antimicrobial compositions comprising esters of hydroxycarboxylic acids.
|
US20080075793A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Dunshee Wayne K |
Antiviral compositions and methods of use
|
EP2060192B9
(en)
*
|
2007-10-17 |
2016-05-04 |
Rudolf Wild GmbH & Co. KG |
Composition comprising lemon balm extracts
|
JP2009155257A
(en)
*
|
2007-12-26 |
2009-07-16 |
Taiyo Corp |
Antibacterial agent and oral composition, food and drink containing the same
|
ES2344673B1
(en)
|
2008-08-07 |
2011-05-03 |
Italfarmaco, S.A. |
USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF POTOLOGIATUMORAL.
|
ES2344675B1
(en)
|
2008-12-19 |
2011-04-28 |
Italfarmaco, S.A. |
USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF VARIUM VARCOLOGY.
|
DE102009008094A1
(en)
|
2009-02-09 |
2010-08-19 |
Barnikol-Keuten, Doris, Dr. |
In situ adhesive gel-forming preparations, in particular for topical application to moisturized skin / mucosa
|
PL3023009T3
(en)
|
2009-08-06 |
2017-07-31 |
Anitox Corporation |
Water and feed preservative
|
WO2011057133A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
JP5864429B2
(en)
|
2009-11-09 |
2016-02-17 |
スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc |
Crosslinked hydrogel composition, method of forming hydrogel composition, and kit
|
WO2012035751A1
(en)
*
|
2010-09-14 |
2012-03-22 |
日油株式会社 |
Antibacterial cleaning composition
|
JP5749915B2
(en)
*
|
2010-11-02 |
2015-07-15 |
花王株式会社 |
Autoinducer-2 inhibitor
|
WO2012078155A1
(en)
*
|
2010-12-09 |
2012-06-14 |
The Research Foundation Of State University Of New York |
Nitric oxide and its biomedical significance
|
EP2696677B1
(en)
|
2011-04-13 |
2021-08-11 |
BioSafe Technologies, Inc. |
Insecticide, insect repellant and anti-irritation composition
|
CA2848777A1
(en)
|
2011-10-20 |
2013-04-25 |
Anitox Corporation |
Antimicrobial formulations with pelargonic acid
|
EP2785205B1
(en)
|
2011-11-30 |
2020-12-30 |
Anitox Corporation |
Antimicrobial mixture of aldehydes, organic acids and organic acid esters
|
HUE055946T2
(en)
*
|
2016-06-20 |
2022-01-28 |
Capretto Ehf |
Synergistic effects, augmenting antimicrobial effects of lipids
|
US20200069630A1
(en)
*
|
2016-07-11 |
2020-03-05 |
Hennipen Life Sciences, Llc |
Compositions for sexually transmitted diseases
|
JP6754030B2
(en)
*
|
2017-04-20 |
2020-09-09 |
マイクロアルジェコーポレーション株式会社 |
Method for Producing Monoacylglycerol, Antibacterial Agent, and Monoacylglycerol
|
US11246872B2
(en)
|
2019-06-14 |
2022-02-15 |
Propella Therapeutics, Inc. |
Topical acyclovir formulations and uses thereof
|
US11572342B2
(en)
|
2020-09-18 |
2023-02-07 |
Niche Biopharmaceuticals LLC |
Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
|